Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge

PLoS ONE(2021)10.1371/journal.pone.0240495Source: DataRank Database

Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge is a research paper published in PLoS ONE (2021). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: goldTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

LaRene Kuller,Ingrid A. Beck ORCID,Che‐Chung Tsai,Jaimy P. Joy,Thera Mulvania

Live enrichment

PubMed:33914754 PMC:PMC8084236 OpenAlex:https://openalex.org/W3158845100

National Institutes of Health

Grant: R01 RR13273

National Institutes of Health

Grant: AI30034

National Institutes of Health

Grant: RR-00166

NIAID NIH HHS

Grant: N01 AI030034

NCRR NIH HHS

Grant: P51 RR000166

FWCI

0.00

Citation Percentile

0.0%

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0240495&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0240495&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0240495

journalhttps://doi.org/10.1371/journal.pone.0240495

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33914754

Fields of Study

HIV Research and TreatmentHIV/AIDS Research and InterventionsHIV-related health complications and treatmentsAnimalsAnti-Retroviral AgentsDisease Models, AnimalFemaleHIV InfectionsHIV-2HumansImmunizationMacaca nemestrinaPre-Exposure ProphylaxisSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusTenofovir

MeSH Terms

TenofovirAnimalsDisease Models, AnimalFemaleHumansImmunizationMacaca nemestrinaSimian Immunodeficiency VirusHIV-2HIV InfectionsSimian Acquired Immunodeficiency SyndromeAnti-Retroviral AgentsPre-Exposure ProphylaxisSimian immunodeficiency virus

Keywords

VirologyVirusSimian immunodeficiency virusImmunologyBiologyLentivirusImmunityELISPOTImmunizationAntibodyViral loadImmune systemViral diseaseMedicineT cell

Sustainable Development Goals

SDG 0: Good health and well-being

Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge

FAIR Checklist

Authors (9)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)